What to do if you are hearing a lot of talk about hearing loss and/or loss of speech in adults?
How to diagnose it and how to correct it?
These are the questions raised by the recent announcement by the Australian National Audit Office (ANZAO) that adult hearing loss is more prevalent than previously thought.
It is not the first time the ANZAE has published such a report, and it is not likely to be the last.
The problem with the ANO’s analysis is that it does not take into account the underlying cause of hearing loss.
In a nutshell, hearing loss in adults is caused by a combination of genetic, environmental and genetic factors, and most of the time, they can be prevented by treatment with oral rehydration salts (ORS).
Although ORS is available over-the-counter, it is a prescription drug.
To avoid the side effects of medication, the majority of adults have to take it regularly.
But not all adults have access to ORS.
Some adults in need of treatment do not have access at all, or for those who have difficulty using ORS, it can take months or years to get the drug to their lips.
And if the drug is not available, some patients find that they need to go to the doctor for an injection of a different drug to get their hearing back.
To be clear, the ANAO does not recommend that adults should rely on oral rehysterectomy or other surgery to treat hearing loss, or that they should rely only on oral ORS for the rest of their lives.
And although ORS can be used to prevent hearing loss from the underlying causes, it may not be effective for the majority who are hearing impaired.
What is ORS?
ORS (or Orthodontic Oral Rehydration) is a non-invasive treatment that is currently available in Australia.
It consists of an injection into the mouth with a saline solution that is then absorbed into the skin through a process known as lipolysis.
This is achieved by mixing the saline solution with water and allowing it to be absorbed into a small plastic tube.
The saline solution then dissolves in the skin cells.
The body’s own enzymes work to break down the salts and produce new proteins.
Once the solution has been dissolved in water, the saline is then infused into the affected area.
When the solution is absorbed into cells, it creates a barrier that prevents the body’s immune system from attacking the damaged tissue.
How is ORs different to other treatments?
ORS has been used successfully for decades in the treatment of many different types of hearing impairment, including hearing loss due to diabetes mellitus, chronic pain, and traumatic brain injury.
A recent report by the Cochrane Collaboration (CC) showed that ORS was effective in preventing hearing loss among adults with diabetes mellitis, and had been used to treat chronic pain and traumatic head injury.
Other reports have also shown that ORs are effective in treating hearing loss associated with traumatic brain injuries.
Is ORS safe?
ORS can help to reduce hearing loss but is not a cure-all.
There are serious concerns about the safety of ORS and the possibility of adverse reactions.
Some studies have shown that certain patients have more hearing loss than others.
This is due to differences in the genetic makeup of the cells in the affected areas.
Other studies have found that ORA is not effective in the majority people with hearing loss with or without diabetes mellus, and that ORAS is not safe for people with certain conditions.
Although the ANSAs findings do not imply ORS should be used for everyone, it does raise important questions about its long-term safety.
Are ORS injections safe?
There are a number of studies to show that ORAs injections are safe.
Two studies found that oral ORAS was effective for patients with diabetes in managing their hearing loss: one in Germany, and one in the UK.
In the first study, published in 2013, patients with mild hearing loss were injected with a solution of 1,000 mg of ORA per day.
“This was followed by a period of 30 days of therapy,” the researchers concluded.
“After one month, there was no difference in the extent of hearing decline in the patients receiving oral ORA versus the patients with hearing decline who received an injection.”
In the second study, the same researchers found that the oral ORAs had no effect on hearing loss rates in people with diabetes.
Both studies included patients with severe hearing loss who were undergoing ORA treatment.
Both studies found a reduction in hearing loss after two months of therapy.
However, the researchers were cautious to note that the results could not be generalized to other conditions with hearing impairment.
If ORAS injections are